Procyon Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Sell |
18,473
-58,754
| -76% | -$4.06M | 0.12% | 158 |
|
|
2025
Q1 | $5.36M | Buy |
77,227
+21,756
| +39% | +$1.51M | 0.32% | 70 |
|
|
2024
Q4 | $4.77M | Sell |
55,471
-8,178
| -13% | -$703K | 0.3% | 74 |
|
|
2024
Q3 | $7.58M | Buy |
63,649
+4,010
| +7% | +$478K | 0.52% | 44 |
|
|
2024
Q2 | $8.51M | Buy |
59,639
+2,297
| +4% | +$328K | 0.63% | 40 |
|
|
2024
Q1 | $7.36M | Buy |
57,342
+2,316
| +4% | +$297K | 0.57% | 43 |
|
|
2023
Q4 | $5.69M | Buy |
55,026
+17,783
| +48% | +$1.84M | 0.48% | 43 |
|
|
2023
Q3 | $3.39M | Buy |
37,243
+19,701
| +112% | +$1.79M | 0.35% | 70 |
|
|
2023
Q2 | $1.42M | Buy |
17,542
+13,490
| +333% | +$1.09M | 0.18% | 130 |
|
|
2023
Q1 | $322K | Buy |
+4,052
| New | +$322K | 0.05% | 299 |
|
|
2020
Q3 | – | Sell |
-50
| Closed | -$2K | – | 752 |
|
|
2020
Q2 | $2K | Buy |
50
+8
| +19% | +$320 | ﹤0.01% | 933 |
|
|
2020
Q1 | $1K | Sell |
42
-38
| -48% | -$905 | ﹤0.01% | 940 |
|
|
2019
Q4 | $2K | Buy |
+80
| New | +$2K | ﹤0.01% | 898 |
|